1 |
Management guideline for the off-label use of medicine in China (2021) |
|
| | Wei Zuo, Yajia Sun, Rongji Liu, Liping Du, Nan Yang, Wenjuan Sun, Ping Wang, Xiaowan Tang, Yunlan Liu, Yuanyuan Ma, Min Meng, Ruobing Lei, Xuelian Yan, Hua Peng, Qing Chang, Hui Pan, Bo Zhang, Yaolong Chen, Shuyang Zhang | | | Expert Review of Clinical Pharmacology. 2022; 4(2): 87 | | | [Pubmed] [Google Scholar] [DOI] | | 2 |
Controversies in off-label prescriptions in dermatology: the perspective of the patient, the physician, and the pharmaceutical companies |
|
| | Katlein França, Sergio Litewka | | | International Journal of Dermatology. 2019; 58(7): 788 | | | [Pubmed] [Google Scholar] [DOI] | | 3 |
TREATMENT OF URTICARIA OFF-LABEL |
|
| | I V Danilycheva, I O Pecherey | | | Russian Journal of Allergy. 2012; 9(6): 15 | | | [Pubmed] [Google Scholar] [DOI] | | 4 |
Off with the label and on the Avastin bandwagon: Why now and how far |
|
| | Santhan Gopal, K.S. | | | Indian Journal of Ophthalmology. 2009; 57(4): 253-256 | | | [Pubmed] [Google Scholar] | |
|